{"id":"https://openalex.org/W4290805780","doi":"https://doi.org/10.1016/j.clinthera.2022.07.006","title":"Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial","display_name":"Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial","alternate_titles":[],"publication_year":2022,"publication_date":"2022-08-11","ids":{"openalex":"https://openalex.org/W4290805780","doi":"https://doi.org/10.1016/j.clinthera.2022.07.006","pmid":"https://pubmed.ncbi.nlm.nih.gov/35965109"},"language":"en","primary_location":{"id":"doi:10.1016/j.clinthera.2022.07.006","doi":"https://doi.org/10.1016/j.clinthera.2022.07.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2022.07.006","pdf_url":"http://www.clinicaltherapeutics.com/article/S0149291822002387/pdf","source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4290805780"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.clinicaltherapeutics.com/article/S0149291822002387/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083670329","display_name":"Gail L. Torkildsen","orcid":"https://orcid.org/0000-0002-2898-7519","observed_orcids":["https://orcid.org/0000-0002-2898-7519"]},"institutions":[{"id":"https://openalex.org/I4210090529","display_name":"Andover Eye Associates","ror":"https://ror.org/00gb2qm43","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210090529"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gail L. Torkildsen","raw_affiliation_strings":["Andover Eye Associates, Andover, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Andover Eye Associates, Andover, Massachusetts","institution_ids":["https://openalex.org/I4210090529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013729227","display_name":"Guruprasad R. Pattar","orcid":"https://orcid.org/0009-0009-1534-554X","observed_orcids":["https://orcid.org/0009-0009-1534-554X"]},"institutions":[{"id":"https://openalex.org/I4210100697","display_name":"The Eye Care Institute","ror":"https://ror.org/01xz2wh36","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210100697"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guruprasad R. Pattar","raw_affiliation_strings":["Eye Care Institute, Louisville, Kentucky"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eye Care Institute, Louisville, Kentucky","institution_ids":["https://openalex.org/I4210100697"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012011016","display_name":"Gary W. Jerkins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary Jerkins","raw_affiliation_strings":["Nashville Vision Associates, Nashville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nashville Vision Associates, Nashville, Tennessee","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050905083","display_name":"Kristen Striffler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristen Striffler","raw_affiliation_strings":["Oyster Point Pharma Inc, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oyster Point Pharma Inc, Princeton, New Jersey","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070495370","display_name":"Jeffrey A. Nau","orcid":"https://orcid.org/0000-0003-0086-3538","observed_orcids":["https://orcid.org/0000-0003-0086-3538"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jeffrey Nau","raw_affiliation_strings":["Oyster Point Pharma Inc, Princeton, New Jersey. Electronic address: jnau@oysterpointrx.com","Oyster Point Pharma Inc, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oyster Point Pharma Inc, Princeton, New Jersey. Electronic address: jnau@oysterpointrx.com","institution_ids":[]},{"raw_affiliation_string":"Oyster Point Pharma Inc, Princeton, New Jersey","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5070495370"],"corresponding_institution_ids":[],"apc_list":{"value":4090,"currency":"USD","value_usd":4090},"apc_paid":{"value":4090,"currency":"USD","value_usd":4090},"fwci":2.3499,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.86766111,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":97},"biblio":{"volume":"44","issue":"9","first_page":"1178","last_page":"1186"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11521","display_name":"Salivary Gland Disorders and Functions","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dry-eye-disease","display_name":"dry eye","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nicotinic-agonists","display_name":"nicotinic agonists","score":0.9549999833106995},{"id":"https://openalex.org/keywords/nasal-spray","display_name":"nasal spray","score":0.9120000004768372},{"id":"https://openalex.org/keywords/single-dose-administration","display_name":"single-dose administration","score":0.734000027179718},{"id":"https://openalex.org/keywords/schirmer-test","display_name":"Schirmer test","score":0.9470000267028809},{"id":"https://openalex.org/keywords/ocular-surface-disease","display_name":"ocular surface disease","score":0.7720000147819519},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5109999775886536},{"id":"https://openalex.org/keywords/eye-irritation","display_name":"eye irritation","score":0.6679999828338623},{"id":"https://openalex.org/keywords/eye-pain","display_name":"ocular pain","score":0.41200000047683716},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4860000014305115},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5419999957084656},{"id":"https://openalex.org/keywords/ocular-surface-inflammation","display_name":"ocular surface inflammation","score":0.3889999985694885},{"id":"https://openalex.org/keywords/ocular-surface-disease-index","display_name":"Ocular Surface Disease Index","score":0.4020000100135803},{"id":"https://openalex.org/keywords/corneal-fluorescein-staining","display_name":"corneal fluorescein staining","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9272602796554565},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5677447319030762},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3809622526168823},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34109967947006226}],"mesh":[{"descriptor_ui":"D000068580","descriptor_name":"Varenicline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015352","descriptor_name":"Dry Eye Syndromes","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D015352","descriptor_name":"Dry Eye Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019793","descriptor_name":"Fluorescein","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D059085","descriptor_name":"Nasal Sprays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.clinthera.2022.07.006","doi":"https://doi.org/10.1016/j.clinthera.2022.07.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2022.07.006","pdf_url":"http://www.clinicaltherapeutics.com/article/S0149291822002387/pdf","source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},{"id":"pmid:35965109","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35965109","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical therapeutics","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1016/j.clinthera.2022.07.006","doi":"https://doi.org/10.1016/j.clinthera.2022.07.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2022.07.006","pdf_url":"http://www.clinicaltherapeutics.com/article/S0149291822002387/pdf","source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4290805780.pdf","grobid_xml":"https://content.openalex.org/works/W4290805780.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1948817653","https://openalex.org/W1969746337","https://openalex.org/W2010954738","https://openalex.org/W2021015098","https://openalex.org/W2027975733","https://openalex.org/W2028465131","https://openalex.org/W2040106038","https://openalex.org/W2048403126","https://openalex.org/W2104838343","https://openalex.org/W2136938154","https://openalex.org/W2144919760","https://openalex.org/W2291473961","https://openalex.org/W2346421161","https://openalex.org/W2596272934","https://openalex.org/W2607173252","https://openalex.org/W2737787547","https://openalex.org/W2739359388","https://openalex.org/W2739410682","https://openalex.org/W2758061472","https://openalex.org/W2794921711","https://openalex.org/W2805411535","https://openalex.org/W2900496685","https://openalex.org/W2972904630","https://openalex.org/W3011235219","https://openalex.org/W3011570543","https://openalex.org/W3029361298","https://openalex.org/W3048831287","https://openalex.org/W3080169204","https://openalex.org/W3212838083","https://openalex.org/W4200467235"],"related_works":["https://openalex.org/W4200467235","https://openalex.org/W3212838083","https://openalex.org/W4392214421","https://openalex.org/W4200345915","https://openalex.org/W4389486158","https://openalex.org/W4307465054","https://openalex.org/W4323043923","https://openalex.org/W4318934904","https://openalex.org/W4384342245","https://openalex.org/W7169853720"],"abstract_inverted_index":{"PURPOSE:":[0],"Dry":[1,65],"eye":[2,32,92,136,253,385,424],"disease":[3],"is":[4,409],"a":[5,69,171,180,373,410],"multifactorial":[6],"disorder":[7],"that":[8,73,400],"affects":[9],"the":[10,37,54,75,201,215,247,256,358,406],"ocular":[11,16,235,348],"surface,":[12],"with":[13,90,270,314,388,422],"symptoms":[14,250],"including":[15],"irritation,":[17],"impaired":[18],"vision,":[19],"and":[20,62,77,169,187,212,234,249,260,293,302,337,355,357,365,378,383,412],"pain.":[21],"Nicotinic":[22],"acetylcholine":[23],"receptor":[24],"(nAChR)":[25],"agonists":[26],"are":[27],"novel":[28],"treatments":[29],"for":[30,121],"dry":[31,91,252,423],"disease;":[33],"this":[34],"study":[35,72,175],"investigates":[36],"nAChR":[38],"agonist":[39,401],"OC-02":[40,57,80,155,244,271,285,318,331,341,370],"(simpinicline":[41,81],"solution)":[42,82,394],"as":[43],"an":[44,104],"aqueous":[45],"nasal":[46,83,181,395,407],"spray.":[47],"METHODS:":[48],"PEARL":[49],"(Clinical":[50],"Trial":[51],"to":[52,148,205,219,267,309,415],"Evaluate":[53],"Efficacy":[55],"of":[56,64,79,97,174,251,317,375,391,403],"Nasal":[58],"Spray":[59],"on":[60,135],"Signs":[61],"Symptoms":[63],"Eye":[66],"Disease)":[67],"was":[68,343],"Phase":[70],"II":[71],"evaluated":[74],"efficacy":[76,196],"safety":[78],"spray":[84,182],"(OC-02":[85],"SNS)":[86],"in":[87,116,200,214,405,420],"adult":[88],"patients":[89,421],"disease.":[93,254,425],"Patients":[94,140],"\u226522":[95],"years":[96],"age":[98],"were":[99,132,144,198,238,263,305,351,363],"eligible":[100],"if":[101],"they":[102],"had":[103],"Ocular":[105],"Surface":[106],"Disease":[107],"Index":[108],"score":[109,114,127,138],"\u226523,":[110],"corneal":[111],"fluorescein":[112],"staining":[113],"\u22652":[115],">1":[117],"region":[118],"or":[119,124,154,161],"\u22654":[120],"all":[122,241],"regions,":[123],"Schirmer":[125],"test":[126],"(STS)":[128],"\u226410":[129],"mm;":[130,282,288,292],"there":[131],"no":[133],"restrictions":[134],"dryness":[137],"(EDS).":[139],"(N":[141],"=":[142,152,165],"165)":[143],"randomly":[145],"assigned":[146],"1:1:1:1":[147],"vehicle":[149,274,321],"(control;":[150],"n":[151,164],"42)":[153],"SNS":[156,245,272,319,342,371],"(0.11":[157],"mg,":[158,160,290,295,335,339],"0.55":[159,289,334],"1.1":[162,294,338],"mg;":[163],"41":[166],"per":[167],"group)":[168],"received":[170],"single":[172],"dose":[173],"drug":[176],"(100":[177],"\u00b5L":[178],"using":[179],"atomizer)":[183],"at":[184],"visit":[185,188,193],"1":[186],"2":[189,347],"(15-19":[190],"days":[191],"after":[192,207,222,268,312],"1).":[194],"Primary":[195],"outcomes":[197],"change":[199,213,277,324],"STS":[202],"from":[203,217,265,278,307,325],"baseline":[204],"immediately":[206,377],"treatment":[208,223,269,313],"administration":[209],"(visit":[210,229],"1)":[211],"EDS":[216],"before":[218,266,308],"5":[220,310],"minutes":[221,311],"during":[224],"controlled":[225],"adverse":[226,349],"environment":[227],"exposure":[228],"2).":[230],"FINDINGS:":[231],"Baseline":[232],"demographic":[233],"clinical":[236],"characteristics":[237],"similar":[239],"across":[240],"groups.":[242],"Single-dose":[243,369],"improved":[246,384],"signs":[248],"For":[255,298],"STS,":[257],"statistically":[258,300],"significant":[259,301],"dose-dependent":[261,303],"improvements":[262,304],"found":[264,306],"versus":[273,320],"(least-squares":[275,322],"mean":[276,323],"baseline:":[279,326],"vehicle,":[280,327],"3.0":[281],"0.11":[283,329],"mg":[284,330],"SNS,":[286,332],"9.0":[287],"17.5":[291],"19.6":[296],"mm).":[297],"EDS,":[299],"higher":[315],"doses":[316,376],"-6.5;":[328],"-9.4;":[333],"-17.4;":[336],"-20.7).":[340],"well":[344],"tolerated:":[345],"only":[346],"events":[350,362],"reported":[352],"(eye":[353],"pruritis":[354],"keratitis),":[356],"most":[359],"common":[360],"nonocular":[361],"cough":[364],"throat":[366],"irritation.":[367],"IMPLICATIONS:":[368],"over":[372],"range":[374],"significantly":[379],"increased":[380],"tear":[381,418],"production":[382,419],"dryness.":[386],"Together":[387],"previous":[389],"studies":[390],"OC-01":[392],"(varenicline":[393],"spray,":[396],"our":[397],"findings":[398],"suggest":[399],"stimulation":[402],"nAChRs":[404],"cavity":[408],"valid":[411],"effective":[413],"mechanism":[414],"elicit":[416],"natural":[417],"CLINICALTRIALS:":[426],"gov":[427],"identifier:":[428],"NCT03452397.":[429]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4290805780","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-08-12T00:00:00"}
